A byline looks simple until a multi-site field study produces a manuscript with fourteen names on it, only some of whom actually wrote a word of the paper. Global health research is especially prone to this problem: a study spanning a ministry of health, an implementing NGO, and a university partner routinely accumulates contributors whose roles range from designing the protocol to simply approving a budget line. Deciding who belongs on the byline — and what each of those people must disclose — is one of the more consequential, and least visible, jobs of an editorial desk. This is the standard this desk applies, and why it is stricter than most contributors expect.
The Four-Part Authorship Test
The working definition used across biomedical and global health publishing comes from the International Committee of Medical Journal Editors (ICMJE). It sets four criteria, and a contributor must satisfy all four — not just one or two — to be listed as an author:
- Substantial contribution. A real role in conceiving or designing the work, or in acquiring, analyzing, or interpreting the data. "Substantial" is meant literally: a contribution without which the work, or a defined part of it, could not have been completed.
- Drafting or critical revision. Participation in writing the manuscript or revising it for important intellectual content — not a read-through and a sign-off, but engagement with the argument itself.
- Final approval. Explicit sign-off on the version that is actually submitted for publication.
- Accountability. Agreement to answer for the accuracy and integrity of the whole work, not just the section a given contributor wrote.
All four have to be true for the same person. A statistician who ran the entire analysis but never saw a draft of the discussion section has not met the standard. Neither has a department head who supervised the project loosely and asked to be included out of courtesy.
What Doesn’t Qualify — and Why It Matters
The ICMJE framework is explicit that several common contributions, on their own, do not meet the bar for authorship: acquiring funding, general supervision of a research group, technical data collection, or simply providing patients, specimens, or field access. These are real contributions, and the correct response is acknowledgment, not a byline. Conflating the two is where "gift authorship" and "guest authorship" creep in — a senior figure added for institutional weight, or a funder’s representative listed as a courtesy. Both distort the scientific record: they misattribute accountability to someone who cannot actually answer for the work, and they understate the true division of labor to a reader trying to judge how much independent scrutiny a finding received.
The responsibility for sorting this out sits with the contributor group itself, not with editors. What an editorial desk can and does do is ask for it in writing: a contribution statement identifying, by name, who did what, checked against the four-part test before a manuscript proceeds to review.
Disclosure Sits Next to Authorship, Not After It
Authorship and conflict-of-interest disclosure are handled as a single step for a reason: both exist to tell a reader how much independent judgment shaped a paper. The standard tool is the ICMJE’s disclosure form, used across most biomedical and global health journals, which asks each listed author to report financial and non-financial relationships covering roughly the three years prior to submission.
Financial vs. Non-Financial: What Actually Gets Disclosed
| Financial conflicts | Non-financial conflicts |
|---|---|
| Employment, consulting fees, or honoraria from an entity affected by the findings | A close personal relationship with someone whose work is discussed in the manuscript |
| Stock or stock options in a relevant company | Direct academic rivalry with another group working the same question |
| Patents or royalties tied to the subject matter | An unpaid but relevant advisory or leadership role |
| Research grants from commercial funders (public and charitable funding generally excluded unless the funder itself has a financial stake) | A prior publication record that commits the author to a particular theory or method |
| Paid lectures, expert testimony, or travel and meeting expenses covered by an interested party | Involvement with an advocacy organization connected to the article’s subject |
Financial disclosure also extends to a spouse or to children under 18, on the reasoning that a household’s financial interest can shape judgment as much as a personal one. Non-financial conflicts are the harder category in practice, because they rely on an author’s own honesty about intellectual or institutional loyalties that carry no dollar figure — a strong prior commitment to a particular intervention, for instance, or a long-standing collaboration with the group whose results are being critiqued. Disclosure does not disqualify a submission; it gives the reader the information needed to weigh it.
How This Desk Applies It
In practice, the two checks run together: a contribution statement mapped against the four-part authorship test, and a disclosure form collected from every listed author before a manuscript enters review, not after acceptance. Neither check judges the quality of the science. Both exist so that when this desk publishes a finding on a vaccination campaign, a diagnostic evaluation, or a field-deployed intervention, a reader can see exactly who is accountable for the claim and what interests, financial or otherwise, might have shaped how it was framed. That transparency is a small, procedural thing next to the underlying research — but it is the part of the process a reader can actually verify.